Kush Dalal - Concepedia

Author

Kush Dalal

University of British Columbia

Also Known As

Dalal, Kush, K. Dalal, Kush Dalal

Publications

Citations

H-Index

Concepts

All Affiliations

University of British Columbia University of Illinois Urbana-Champaign Simon Fraser University Vancouver General Hospital

About

Kush Dalal is an author at University of British Columbia specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	627
2	Natural Sciences	7	7	322
3	Biochemistry	3	3	94
4	Cell Biology	2	2	64
5	Biomolecular Engineering	1	1	10

Kush Dalal

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang, Cell Reports	2022	452
Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling Bruno D. Fonseca, Graham H. Diering, Michael Bidinosti, Journal of Biological Chemistry	2012	160
Nanodiscs unravel the interaction between the SecYEG channel and its cytosolic partner SecA Mériem Alami, Kush Dalal, Barbara Lelj‐Garolla, The EMBO Journal Secyeg ChannelCytosolic Partner SecaNanotechnologyMedicineMolecular Biology	2007	148
Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer Kush Dalal, Mani Roshan‐Moniri, Aishwariya Sharma, Journal of Biological Chemistry Androgen ReceptorDrug TargetingHormonal ReceptorReceptor (Biochemistry)Molecular Biology	2014	129
Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor Huifang Li, Fuqiang Ban, Kush Dalal, Journal of Medicinal Chemistry Drug TargetMolecular BiologyMedicinal ChemistryBinding SiteAnti-cancer Agent	2014	116
Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action Fuqiang Ban, Kush Dalal, Huifang Li, Journal of Chemical Information and Modeling	2017	112
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201) Hendrik Borgmann, Nada Lallous, Deniz Özistanbullu, European Urology Androgen ReceptorNovel Inhibitor DarolutamideUrologyGenitourinary CancerMedicine	2017	104
Androgen receptor-binding sites are highly mutated in prostate cancer Tunç Morova, Daniel R. McNeill, Nada Lallous, Nature Communications	2020	59
RPA nucleic acid-binding properties of IFI16-HIN200 Hongyue Yan, Kush Dalal, Benjamin Hon, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Natural SciencesOligonucleotideDna ReplicationMolecular Biology	2008	53
SecYEG activates GTPases to drive the completion of cotranslational protein targeting David Akopian, Kush Dalal, Kuang Shen, The Journal of Cell Biology	2013	53

Page 1